FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 99 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q1 2022. The put-call ratio across all filers is 6.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $96,000 | -94.7% | 10,291 | -91.9% | 0.00% | -100.0% |
Q4 2021 | $1,815,000 | -21.6% | 127,631 | +27.9% | 0.00% | 0.0% |
Q3 2021 | $2,314,000 | +1.6% | 99,776 | +9.1% | 0.00% | 0.0% |
Q2 2021 | $2,277,000 | +52.3% | 91,487 | +71.5% | 0.00% | 0.0% |
Q1 2021 | $1,495,000 | +30.9% | 53,350 | +63.1% | 0.00% | 0.0% |
Q4 2020 | $1,142,000 | -2.2% | 32,714 | +39.5% | 0.00% | 0.0% |
Q3 2020 | $1,168,000 | – | 23,445 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |